Scientists are studying how GLP-1 drugs, such as Ozempic and Wegovy, affect brain areas that regulate hunger, nausea, pleasure-based eating, and thirst. Their findings could lead to new treatments that maintain weight loss benefits while minimizing adverse side effects.
Source: All Top News — ScienceDaily